Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-5_03-cv-05669/USCOURTS-cand-5_03-cv-05669-22/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

 REQUEST FOR CASE MANAGEMENT CONFERENCE

CASE NO. C 03 05669 (JW) 

[List of Counsel Appears Below] 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

THE REGENTS OF THE UNIVERSITY OF 

CALIFORNIA, a California corporation, 

Plaintiff, 

v. 

MICRO THERAPEUTICS, INC., a Delaware 

corporation, DENDRON GmbH, a German 

corporation, and ev3 Inc., a Delaware corporation, 

Defendants and Counterclaim 

And Third Party Plaintiffs, 

v. 

BOSTON SCIENTIFIC CORPORATION, a 

Delaware corporation, and TARGET 

THERAPEUTICS, INC., a Delaware corporation, 

Third Party Defendants. 

 

Case No.: C 03 05669 (JW) (RS) 

REQUEST FOR CASE 

MANAGEMENT CONFERENCE AND 

[PROPOSED ORDER] 

Date: January 22, 2007 

Time: 10:00 a.m. 

Hon. James Ware 

Pursuant to Civil Local Rules 16-10(c), Defendant and Third Party Plaintiffs Micro 

Therapeutics, Inc., Dendron GmbH and ev3 Inc. (collectively referred to herein as “MTI”), request 

that the Court schedule a case management conference to address issues relating to the status of the 

case, including without limitation, a briefing and hearing schedule for summary judgment motions 

as well as motions in limine. Under the current schedule, dispositive motions are due by April 2, 

2007. Trial is scheduled to begin on June 5, 2007. 

----------------------------

--- 23

Case 5:03-cv-05669-JW Document 387 Filed 01/12/07 Page 1 of 3
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

2 

REQUEST FOR CASE MANAGEMENT CONFERENCE

CASE NO. C 03 05669 (JW) 

MTI further requests that the Court permit the parties to file a Joint Case Management 

Conference Statement pursuant to Local Rule 16-10(d) by January 16, 2007. 

Counsel for Plaintiffs, The Regents of the University of California, has indicated that The 

Regents joins in this request. Counsel for Third Party Defendants, Boston Scientific and Target 

Therapeutics, has indicated that Third Party Defendants do not object to this request. All parties are 

scheduled to be present at the Court on the requested date of January 22, 2007 for motion hearings 

at 9:00 a.m. 

Respectfully submitted, 

DATED: January 11, 2007. By: ___/s/ Michelle M. Umberger___________ 

HELLER EHRMAN LLP 

Michael K. Plimack (Bar No. 133869) 

Michael.Plimack@Hellerehrman.com 

333 Bush Street 

San Francisco, CA 94104-2878 

Telephone: (415) 772-6000 

HELLER EHRMAN LLP 

John S. Skilton (Pro Hac Vice) 

John.Skilton@Hellerehrman.com 

David J. Harth (Pro Hac Vice) 

David.Harth@Hellerehrman.com 

Charles G. Curtis, Jr. (Pro Hac Vice) 

Charles.Curtis@Hellerehrman.com 

Michelle M. Umberger (Pro Hac Vice) 

Michelle.Umberger@Hellerehrman.com 

Gabrielle E. Bina (Pro Hac Vice) 

Gabrielle.Bina@Hellerehrman.com 

Sarah C. Walkenhorst (Pro Hac Vice) 

Sarah.Walkenhorst@Hellerehrman.com 

One East Main Street, Suite 201 

Madison, WI 53703 

Telephone: (608) 663-7460 

Facsimile: (608) 663-7499 

Attorneys for Defendants/Counterclaimants and Third 

Party Plaintiffs MICRO THERAPEUTICS, INC., 

DENDRON GmbH and ev3 INC. 

23---

Case 5:03-cv-05669-JW Document 387 Filed 01/12/07 Page 2 of 3
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

3 

REQUEST FOR CASE MANAGEMENT CONFERENCE

CASE NO. C 03 05669 (JW) 

IT IS SO ORDERED

 Dated: 

 Honorable James Ware 

 United States District Court Judge 

 Northern District of California 

Jan 12, 2007

Case 5:03-cv-05669-JW Document 387 Filed 01/12/07 Page 3 of 3